Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung Cancer
The goal of this clinical trial is to compare the efficacy and safety of trilaciclib versus placebo in subjects with limited stage small cell lung cancer. The …
Limited Stage Small Cell Lung Cancer
Estimated
~$10 – $8,750
Pharmacosmos A/SNCT07473128
Phase 2
An Open-label, Randomized Study of BMS-986489 (Atigotatug + Nivolumab Fixed-dose Combination) vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
This is an open-label, randomized study of BMS-986489 (atigotatug + nivolumab fixed-dose combination) vs durvalumab in limited-stage (LS)-small-cell lung cance…
Limited Stage Small Cell Lung Cancer
Estimated
~$10 – $8,750
SCRI Development Innovations, LLCNCT06773910